{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T03:21:47Z","timestamp":1793762507903,"version":"4.6.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T00:00:00Z","timestamp":1695168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T00:00:00Z","timestamp":1695168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007514","name":"Universit\u00e0 di Pisa","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007514","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>Amiodarone-induced thyrotoxicosis is associated with high morbidity and mortality rates. The approach to this condition is widely variable across different medical specialists and even among expert endocrinologists. As a matter of fact, the approach to amiodarone-induced thyrotoxicosis has always been considered difficult, due to diagnostic uncertainties easily resulting in missteps, and therapeutic challenges easily resulting in unresponsiveness or slow-responsiveness to the administered drugs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Our purpose is to review novelties emerged during the last years about this condition, with the aim to provide novel insights on the diagnostic and therapeutic management of this challenging condition.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s40618-023-02168-3","type":"journal-article","created":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T18:02:28Z","timestamp":1695232948000},"page":"275-283","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Short review: novel concepts in the approach to patients with amiodarone-induced thyrotoxicosis"],"prefix":"10.1007","volume":"47","author":[{"given":"D.","family":"Cappellani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Bartalena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5975-4411","authenticated-orcid":false,"given":"F.","family":"Bogazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,20]]},"reference":[{"issue":"5","key":"2168_CR1","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1089\/105072501300176471","volume":"11","author":"F Bogazzi","year":"2001","unstructured":"Bogazzi F, Bartalena L, Gasperi M, Braverman LE, Martino E (2001) The various effects of amiodarone on thyroid function. Thyroid 11(5):511\u2013519","journal-title":"Thyroid"},{"issue":"6","key":"2168_CR2","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.beem.2009.07.001","volume":"23","author":"SA Eskes","year":"2009","unstructured":"Eskes SA, Wiersinga WM (2009) Amiodarone and thyroid. Best Pract Res Clin Endocrinol Metab 23(6):735\u2013751","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2168_CR3","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.tcm.2022.01.001","volume":"33","author":"K Mohammadi","year":"2022","unstructured":"Mohammadi K, Shafie D, Vakhshoori M, Bondariyan N, Heidarpour M, Rezvanian H (2022) Prevalence of amiodarone-induced hypothyroidism; A systematic review and meta-analysis: Amiodarone-induced hypothyroidism epidemiology. Trends Cardiovasc Med 33:252","journal-title":"Trends Cardiovasc Med"},{"key":"2168_CR4","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.tcm.2022.01.008","volume":"33","author":"F Bogazzi","year":"2022","unstructured":"Bogazzi F, Cappellani D (2022) The striking prevalence of amiodarone induced hypothyroidism: an endocrinologist\u2019s perspective. Trends Cardiovasc Med 33:263","journal-title":"Trends Cardiovasc Med"},{"issue":"4","key":"2168_CR5","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1111\/j.1365-2265.2004.02119.x","volume":"61","author":"L Bartalena","year":"2004","unstructured":"Bartalena L, Wiersinga WM, Tanda ML, Bogazzi F, Piantanida E, Lai A et al (2004) Diagnosis and management of amiodarone-induced thyrotoxicosis in Europe: results of an international survey among members of the European Thyroid Association. Clin Endocrinol 61(4):494\u2013502","journal-title":"Clin Endocrinol"},{"issue":"4","key":"2168_CR6","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/j.1365-2265.2006.02590.x","volume":"65","author":"LA Diehl","year":"2006","unstructured":"Diehl LA, Romaldini JH, Graf H, Bartalena L, Martino E, Albino CC et al (2006) Management of amiodarone-induced thyrotoxicosis in Latin America: an electronic survey. Clin Endocrinol 65(4):433\u2013438","journal-title":"Clin Endocrinol"},{"issue":"5","key":"2168_CR7","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1111\/j.1365-2265.2008.03268.x","volume":"69","author":"ML Tanda","year":"2008","unstructured":"Tanda ML, Piantanida E, Lai A, Liparulo L, Sassi L, Bogazzi F et al (2008) Diagnosis and management of amiodarone-induced thyrotoxicosis: similarities and differences between North American and European thyroidologists. Clin Endocrinol 69(5):812\u2013818","journal-title":"Clin Endocrinol"},{"key":"2168_CR8","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1210\/clinem\/dgac756","volume":"108","author":"D Cappellani","year":"2022","unstructured":"Cappellani D, Marconcini G, Manetti L, Bartalena L, Bogazzi F (2022) Real-life data on the impact of medical therapy for amiodarone-induced thyrotoxicosis on CV events and hospitalizations. J clin Endocrinol Metabol 108:1298","journal-title":"J clin Endocrinol Metabol"},{"issue":"10","key":"2168_CR9","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1089\/thy.2016.0229","volume":"26","author":"DS Ross","year":"2016","unstructured":"Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, Maia AL et al (2016) 2016 american thyroid association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid 26(10):1343\u20131421","journal-title":"Thyroid"},{"issue":"2","key":"2168_CR10","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1159\/000486957","volume":"7","author":"L Bartalena","year":"2018","unstructured":"Bartalena L, Bogazzi F, Chiovato L, Hubalewska-Dydejczyk A, Links TP, Vanderpump M (2018) 2018 European Thyroid association (ETA) guidelines for the management of amiodarone-associated thyroid dysfunction. Eur Thyroid J 7(2):55\u201366","journal-title":"Eur Thyroid J"},{"issue":"2","key":"2168_CR11","first-page":"423","volume":"78","author":"L Bartalena","year":"1994","unstructured":"Bartalena L, Grasso L, Brogioni S, Aghini-Lombardi F, Braverman LE, Martino E (1994) Serum interleukin-6 in amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab 78(2):423\u2013427","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2168_CR12","first-page":"1402","volume":"26","author":"E Martino","year":"1985","unstructured":"Martino E, Aghini-Lombardi F, Lippi F, Baschieri L, Safran M, Braverman LE et al (1985) Twenty-four hour radioactive iodine uptake in 35 patients with amiodarone associated thyrotoxicosis. J Nucl Med 26(12):1402\u20131407","journal-title":"J Nucl Med"},{"issue":"2","key":"2168_CR13","first-page":"167","volume":"119","author":"E Martino","year":"1988","unstructured":"Martino E, Bartalena L, Mariotti S, Aghini-Lombardi F, Ceccarelli C, Lippi F et al (1988) Radioactive iodine thyroid uptake in patients with amiodarone-iodine-induced thyroid dysfunction. Acta Endocrinol (Copenh) 119(2):167\u2013173","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"2","key":"2168_CR14","first-page":"240","volume":"22","author":"E Martino","year":"2001","unstructured":"Martino E, Bartalena L, Bogazzi F, Braverman LE (2001) The effects of amiodarone on the thyroid. Endocr Rev 22(2):240\u2013254","journal-title":"Endocr Rev"},{"issue":"6","key":"2168_CR15","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1210\/jc.2010-0180","volume":"95","author":"F Bogazzi","year":"2010","unstructured":"Bogazzi F, Bartalena L, Martino E (2010) Approach to the patient with amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab 95(6):2529\u20132535","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2168_CR16","first-page":"340","volume":"35","author":"F Bogazzi","year":"2012","unstructured":"Bogazzi F, Tomisti L, Bartalena L, Aghini-Lombardi F, Martino E (2012) Amiodarone and the thyroid: a 2012 update. J Endocrinol Invest 35(3):340\u2013348","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"2168_CR17","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1210\/clinem\/dgz041","volume":"105","author":"D Cappellani","year":"2020","unstructured":"Cappellani D, Papini P, Pingitore A, Tomisti L, Mantuano M, Di Certo AM et al (2020) Comparison between total thyroidectomy and medical therapy for amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab 105(1):242\u2013251","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2168_CR18","first-page":"1463","volume":"31","author":"D Cappellani","year":"2021","unstructured":"Cappellani D, De Marco G, Ferrarini E, Torregrossa L, Di Certo AM, Cosentino G et al (2021) Identification of two different phenotypes of patients with amiodarone-induced thyrotoxicosis and positive thyrotropin receptor antibody tests. Thyroid 31(10):1463\u20131471","journal-title":"Thyroid"},{"issue":"5","key":"2168_CR19","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1210\/jcem.79.5.7962338","volume":"79","author":"L Bartalena","year":"1994","unstructured":"Bartalena L, Brogioni S, Grasso L, Rago T, Vitti P, Pinchera A et al (1994) Interleukin-6: a marker of thyroid-destructive processes? J Clin Endocrinol Metab 79(5):1424\u20131427","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2168_CR20","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s40618-015-0426-0","volume":"39","author":"L Tomisti","year":"2016","unstructured":"Tomisti L, Urbani C, Rossi G, Latrofa F, Sardella C, Manetti L et al (2016) The presence of anti-thyroglobulin (TgAb) and\/or anti-thyroperoxidase antibodies (TPOAb) does not exclude the diagnosis of type 2 amiodarone-induced thyrotoxicosis. J Endocrinol Invest 39(5):585\u2013591","journal-title":"J Endocrinol Invest"},{"key":"2168_CR21","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2021.0118","author":"D Cappellani","year":"2021","unstructured":"Cappellani D, De Marco G, Ferrarini E, Torregrossa L, Di Certo AM, Cosentino G et al (2021) Identification of two different phenotypes of patients with amiodarone-induced thyrotoxicosis and positive thyrotropin receptor antibody tests. Official Journal Amer Thyroid Assoc. https:\/\/doi.org\/10.1089\/thy.2021.0118","journal-title":"Official Journal Amer Thyroid Assoc."},{"issue":"8","key":"2168_CR22","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1007\/BF03348001","volume":"20","author":"N Takasu","year":"1997","unstructured":"Takasu N, Oshiro C, Akamine H, Komiya I, Nagata A, Sato Y et al (1997) Thyroid-stimulating antibody and TSH-binding inhibitor immunoglobulin in 277 Graves\u2019 patients and in 686 normal subjects. J Endocrinol Invest 20(8):452\u2013461","journal-title":"J Endocrinol Invest"},{"key":"2168_CR23","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s40618-020-01380-9","volume":"44","author":"T Diana","year":"2020","unstructured":"Diana T, Ponto KA, Kahaly GJ (2020) Thyrotropin receptor antibodies and Graves\u2019 orbitopathy. J Endocrinol Invest 44:703","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"2168_CR24","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1309\/AJCPZUT7CNUEU7OP","volume":"139","author":"JJ Leschik","year":"2013","unstructured":"Leschik JJ, Diana T, Olivo PD, K\u00f6nig J, Krahn U, Li Y et al (2013) Analytical performance and clinical utility of a bioassay for thyroid-stimulating immunoglobulins. Am J Clin Pathol 139(2):192\u2013200","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"2168_CR25","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1089\/thy.1997.7.541","volume":"7","author":"F Bogazzi","year":"1997","unstructured":"Bogazzi F, Bartalena L, Brogioni S, Mazzeo S, Vitti P, Burelli A et al (1997) Color flow Doppler sonography rapidly differentiates type I and type II amiodarone-induced thyrotoxicosis. Thyroid 7(4):541\u2013545","journal-title":"Thyroid"},{"issue":"6","key":"2168_CR26","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1089\/thy.2017.0651","volume":"28","author":"A Van den Bruel","year":"2018","unstructured":"Van den Bruel A, Delanote J, Braeckman A, De Vroe C, Pyfferoen L, Ghekiere J et al (2018) \u201cWhite Thyroid\u201d on unenhanced computed tomography in amiodarone-induced thyrotoxicosis Type 2. Thyroid 28(6):769\u2013772","journal-title":"Thyroid"},{"key":"2168_CR27","doi-asserted-by":"publisher","DOI":"10.1530\/ETJ-21-0047","author":"L Felix","year":"2022","unstructured":"Felix L, Jacon P, Lugosi M, Cristante J, Roux J, Chabre O (2022) Rise and fall of thyroid radiologic density during the time course of amiodarone-induced thyrotoxicosis. Eur Thyroid J. https:\/\/doi.org\/10.1530\/ETJ-21-0047","journal-title":"Eur Thyroid J."},{"issue":"1","key":"2168_CR28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1210\/jcem.86.1.7119","volume":"86","author":"GH Daniels","year":"2001","unstructured":"Daniels GH (2001) Amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab 86(1):3\u20138","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2168_CR29","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1530\/EJE-08-0348","volume":"159","author":"M Piga","year":"2008","unstructured":"Piga M, Cocco MC, Serra A, Boi F, Loy M, Mariotti S (2008) The usefulness of 99mTc-sestaMIBI thyroid scan in the differential diagnosis and management of amiodarone-induced thyrotoxicosis. Eur J Endocrinol 159(4):423\u2013429","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2168_CR30","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1097\/MNM.0000000000000260","volume":"36","author":"DA Pattison","year":"2015","unstructured":"Pattison DA, Westcott J, Lichtenstein M, Toh HB, Gunawardana D, Better N et al (2015) Quantitative assessment of thyroid-to-background ratio improves the interobserver reliability of technetium-99m sestamibi thyroid scintigraphy for investigation of amiodarone-induced thyrotoxicosis. Nucl Med Commun 36(4):356\u2013362","journal-title":"Nucl Med Commun"},{"issue":"9","key":"2168_CR31","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1097\/RLU.0000000000002207","volume":"43","author":"S Censi","year":"2018","unstructured":"Censi S, Bodanza V, Manso J, Gusella S, Watutantrige-Fernando S, Cavedon E et al (2018) Amiodarone-Induced thyrotoxicosis: differential diagnosis using 99mtc-sestamibi and target-to-background ratio (TBR). Clin Nucl Med 43(9):655\u2013662","journal-title":"Clin Nucl Med"},{"issue":"7","key":"2168_CR32","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1590\/S0004-27302011000700009","volume":"55","author":"SB Souto","year":"2011","unstructured":"Souto SB, Fernandes H, Matos MJ, Braga DC, Pereira J, Carvalho D (2011) Importance of (99)mTc-sestaMIBI thyroid scan in a case of amiodarone-induced thyrotoxicosis. Arq Bras Endocrinol Metabol 55(7):486\u2013489","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"1071","key":"2168_CR33","doi-asserted-by":"publisher","first-page":"20160836","DOI":"10.1259\/bjr.20160836","volume":"90","author":"J Wang","year":"2017","unstructured":"Wang J, Zhang R (2017) Evaluation of (99m)Tc-MIBI in thyroid gland imaging for the diagnosis of amiodarone-induced thyrotoxicosis. Br J Radiol 90(1071):20160836","journal-title":"Br J Radiol"},{"key":"2168_CR34","first-page":"2493460","volume":"2020","author":"G Elshimy","year":"2020","unstructured":"Elshimy G, Alsayed M, Targovnik J, Sidarous G, Milas KM (2020) The Use of (99m)Tc-Methoxy-isobutyl-isonitrile (sestaMIBI) uptake on scintigraphy ((99m)-STS) in amiodarone-induced thyrotoxicosis: case series and review of the literature. Case Rep Endocrinol 2020:2493460","journal-title":"Case Rep Endocrinol"},{"issue":"9","key":"2168_CR35","doi-asserted-by":"publisher","first-page":"e582","DOI":"10.1097\/RLU.0000000000004332","volume":"47","author":"R Wang","year":"2022","unstructured":"Wang R, Better N, Sivaratnam D, Westcott J, Forehan S, Christie M et al (2022) 99m Tc-sestamibi thyroid scintigraphy in amiodarone-induced thyrotoxicosis functional imaging-histopathologic correlation. Clin Nucl Med 47(9):e582\u2013e584","journal-title":"Clin Nucl Med"},{"issue":"9","key":"2168_CR36","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.1210\/clinem\/dgaa464","volume":"105","author":"D Cappellani","year":"2020","unstructured":"Cappellani D, Papini P, Di Certo AM, Morganti R, Urbani C, Manetti L et al (2020) Duration of exposure to thyrotoxicosis increases mortality of compromised AIT patients: the role of early thyroidectomy. J Clin Endocrinol Metabol 105(9):3427","journal-title":"J Clin Endocrinol Metabol"},{"issue":"8","key":"2168_CR37","first-page":"2930","volume":"81","author":"L Bartalena","year":"1996","unstructured":"Bartalena L, Brogioni S, Grasso L, Bogazzi F, Burelli A, Martino E (1996) Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: results of a prospective study. J Clin Endocrinol Metab 81(8):2930\u20132933","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2168_CR38","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1007\/BF03343984","volume":"25","author":"F Bogazzi","year":"2002","unstructured":"Bogazzi F, Aghini-Lombardi F, Cosci C, Lupi I, Santini F, Tanda ML et al (2002) Iopanoic acid rapidly controls type I amiodarone-induced thyrotoxicosis prior to thyroidectomy. J Endocrinol Invest 25(2):176\u2013180","journal-title":"J Endocrinol Invest"},{"issue":"5","key":"2168_CR39","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1210\/jc.2002-021874","volume":"88","author":"F Bogazzi","year":"2003","unstructured":"Bogazzi F, Bartalena L, Cosci C, Brogioni S, Dell\u2019Unto E, Grasso L et al (2003) Treatment of type II amiodarone-induced thyrotoxicosis by either iopanoic acid or glucocorticoids: a prospective, randomized study. J Clin Endocrinol Metab 88(5):1999\u20132002","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2168_CR40","doi-asserted-by":"publisher","first-page":"3757","DOI":"10.1210\/jc.2009-0940","volume":"94","author":"F Bogazzi","year":"2009","unstructured":"Bogazzi F, Tomisti L, Rossi G, Dell\u2019Unto E, Pepe P, Bartalena L et al (2009) Glucocorticoids are preferable to thionamides as first-line treatment for amiodarone-induced thyrotoxicosis due to destructive thyroiditis: a matched retrospective cohort study. J Clin Endocrinol Metab 94(10):3757\u20133762","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2168_CR41","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1210\/jc.2011-2390","volume":"97","author":"SA Eskes","year":"2012","unstructured":"Eskes SA, Endert E, Fliers E, Geskus RB, Dullaart RP, Links TP et al (2012) Treatment of amiodarone-induced thyrotoxicosis type 2: a randomized clinical trial. J Clin Endocrinol Metab 97(2):499\u2013506","journal-title":"J Clin Endocrinol Metab"},{"issue":"24","key":"2168_CR42","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1016\/j.jacc.2007.02.054","volume":"49","author":"D Conen","year":"2007","unstructured":"Conen D, Melly L, Kaufmann C, Bilz S, Ammann P, Schaer B et al (2007) Amiodarone-induced thyrotoxicosis: clinical course and predictors of outcome. J Am Coll Cardiol 49(24):2350\u20132355","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2168_CR43","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1210\/jc.2008-1907","volume":"94","author":"KH Yiu","year":"2009","unstructured":"Yiu KH, Jim MH, Siu CW, Lee CH, Yuen M, Mok M et al (2009) Amiodarone-induced thyrotoxicosis is a predictor of adverse cardiovascular outcome. J Clin Endocrinol Metab 94(1):109\u2013114","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2168_CR44","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1210\/clinem\/dgz041","volume":"105","author":"D Cappellani","year":"2020","unstructured":"Cappellani D, Papini P, Pingitore A, Tomisti L, Mantuano M, Di Certo AM et al (2020) Comparison between total thyroidectomy and medical therapy for amiodarone-induced thyrotoxicosis. J Clinical Endocrinol Metabol. 105(1):242","journal-title":"J Clinical Endocrinol Metabol."},{"issue":"3","key":"2168_CR45","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/BF03348098","volume":"9","author":"E Martino","year":"1986","unstructured":"Martino E, Aghini-Lombardi F, Mariotti S, Lenziardi M, Baschieri L, Braverman LE et al (1986) Treatment of amiodarone associated thyrotoxicosis by simultaneous administration of potassium perchlorate and methimazole. J Endocrinol Invest 9(3):201\u2013207","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"2168_CR46","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1210\/jc.2006-2059","volume":"92","author":"F Bogazzi","year":"2007","unstructured":"Bogazzi F, Bartalena L, Tomisti L, Rossi G, Tanda ML, Dell\u2019Unto E et al (2007) Glucocorticoid response in amiodarone-induced thyrotoxicosis resulting from destructive thyroiditis is predicted by thyroid volume and serum free thyroid hormone concentrations. J Clin Endocrinol Metab 92(2):556\u2013562","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2168_CR47","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1089\/thy.2018.0274","volume":"29","author":"M Gershinsky","year":"2019","unstructured":"Gershinsky M, Saliba W, Lavi I, Shapira C, Gronich N (2019) Increased risk of antithyroid drug agranulocytosis associated with amiodarone-induced thyrotoxicosis: a population-based cohort study. Thyroid 29(2):193\u2013201","journal-title":"Thyroid"},{"issue":"11","key":"2168_CR48","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1001\/jama.1990.03440110092034","volume":"263","author":"AP Farwell","year":"1990","unstructured":"Farwell AP, Abend SL, Huang SK, Patwardhan NA, Braverman LE (1990) Thyroidectomy for amiodarone-induced thyrotoxicosis. JAMA 263(11):1526\u20131528","journal-title":"JAMA"},{"issue":"11","key":"2168_CR49","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1007\/s00268-004-7599-6","volume":"28","author":"SG Houghton","year":"2004","unstructured":"Houghton SG, Farley DR, Brennan MD, van Heerden JA, Thompson GB, Grant CS (2004) Surgical management of amiodarone-associated thyrotoxicosis: Mayo Clinic experience. World J Surg 28(11):1083\u20131087","journal-title":"World J Surg"},{"issue":"1","key":"2168_CR50","first-page":"45","volume":"124","author":"RM Kaderli","year":"2016","unstructured":"Kaderli RM, Fahrner R, Christ ER, Stettler C, Fuhrer J, Martinelli M et al (2016) Total thyroidectomy for amiodarone-induced thyrotoxicosis in the hyperthyroid state. Exp Clin Endocrinol Diabetes 124(1):45\u201348","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"7","key":"2168_CR51","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1017\/S0022215112000722","volume":"126","author":"C Pierret","year":"2012","unstructured":"Pierret C, Tourtier JP, Pons Y, Merat S, Duverger V, Perrier E (2012) Total thyroidectomy for amiodarone-associated thyrotoxicosis: should surgery always be delayed for pre-operative medical preparation? J Laryngol Otol 126(7):701\u2013705","journal-title":"J Laryngol Otol"},{"issue":"11","key":"2168_CR52","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1007\/s00268-005-0673-x","volume":"30","author":"J Gough","year":"2006","unstructured":"Gough J, Gough IR (2006) Total thyroidectomy for amiodarone-associated thyrotoxicosis in patients with severe cardiac disease. World J Surg 30(11):1957\u20131961","journal-title":"World J Surg"},{"issue":"4","key":"2168_CR53","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1007\/s13304-022-01297-3","volume":"74","author":"S Bakkar","year":"2022","unstructured":"Bakkar S, Cappellani D, Forfori F, Di Salvo C, Catarsi S, Ambrosini CE et al (2022) Early surgery: a favorable prognosticator in amiodarone-induced thyrotoxicosis-a single-center experience with 53 cases. Updat Surg 74(4):1413\u20131418","journal-title":"Updat Surg"},{"key":"2168_CR54","doi-asserted-by":"publisher","DOI":"10.1002\/ohn.405","author":"S Frey","year":"2023","unstructured":"Frey S, Caillard C, Mahot P, Pattier S, Volteau C, Knipping G et al (2023) Mortality after total thyroidectomy for amiodarone-induced thyrotoxicosis according to left ventricular ejection fraction otolaryngology\u2013head and neck surgery. Off J American Acad Otolaryngol-Head Neck Surg. https:\/\/doi.org\/10.1002\/ohn.405","journal-title":"Off J American Acad Otolaryngol-Head Neck Surg"},{"issue":"8","key":"2168_CR55","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1161\/01.CIR.0000085166.44904.79","volume":"108","author":"TJ Wang","year":"2003","unstructured":"Wang TJ, Evans JC, Benjamin EJ, Levy D, LeRoy EC, Vasan RS (2003) Natural history of asymptomatic left ventricular systolic dysfunction in the community. Circulation 108(8):977\u2013982","journal-title":"Circulation"},{"issue":"10","key":"2168_CR56","doi-asserted-by":"publisher","first-page":"3515","DOI":"10.1210\/jc.2012-1797","volume":"97","author":"L Tomisti","year":"2012","unstructured":"Tomisti L, Materazzi G, Bartalena L, Rossi G, Marchello A, Moretti M et al (2012) Total thyroidectomy in patients with amiodarone-induced thyrotoxicosis and severe left ventricular systolic dysfunction. J Clin Endocrinol Metab 97(10):3515\u20133521","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2168_CR57","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.1210\/clinem\/dgaa464","volume":"105","author":"D Cappellani","year":"2020","unstructured":"Cappellani D, Papini P, Di Certo AM, Morganti R, Urbani C, Manetti L et al (2020) Duration of exposure to thyrotoxicosis increases mortality of compromised AIT patients: the Role of early thyroidectomy. J Clin Endocrinol Metab 105(9):3427\u20133436","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2168_CR58","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1530\/eje.1.02122","volume":"154","author":"AJ O'Sullivan","year":"2006","unstructured":"O\u2019Sullivan AJ, Lewis M, Diamond T (2006) Amiodarone-induced thyrotoxicosis: left ventricular dysfunction is associated with increased mortality. Eur J Endocrinol 154(4):533\u2013536","journal-title":"Eur J Endocrinol"},{"key":"2168_CR59","doi-asserted-by":"publisher","first-page":"984981","DOI":"10.1155\/2010\/984981","volume":"2010","author":"P Calis","year":"2010","unstructured":"Calis P, Berendsen R, Logeman A, Sarton E, Aarts L (2010) Anesthetic considerations in a patient with amiodarone-induced thyrotoxicosis. Case Rep Med 2010:984981","journal-title":"Case Rep Med"},{"issue":"6","key":"2168_CR60","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/PL00024613","volume":"22","author":"E Hamoir","year":"1998","unstructured":"Hamoir E, Meurisse M, Defechereux T, Joris J, Vivario J, Hennen G (1998) Surgical management of amiodarone-associated thyrotoxicosis: too risky or too effective? World J Surg 22(6):537\u2013542","journal-title":"World J Surg"},{"issue":"2","key":"2168_CR61","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s00106-013-2806-0","volume":"62","author":"C Meerwein","year":"2014","unstructured":"Meerwein C, Vital D, Greutmann M, Schmid C, Huber GF (2014) Total thyroidectomy in patients with amiodarone-induced hyperthyroidism: when does the risk of conservative treatment exceed the risk of surgery? HNO 62(2):100\u2013105","journal-title":"HNO"},{"key":"2168_CR62","doi-asserted-by":"publisher","first-page":"3036","DOI":"10.1210\/clinem\/dgaa300","volume":"105","author":"D Cappellani","year":"2020","unstructured":"Cappellani D, Bogazzi F (2020) Response to the letter to the editor: \u201ccomparison between total thyroidectomy and medical therapy for amiodarone-induced thyrotoxicosis.\u201d J Clin Endocrinol Metabol 105:3036","journal-title":"J Clin Endocrinol Metabol"},{"issue":"11","key":"2168_CR63","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1210\/js.2018-00259","volume":"2","author":"A Kotwal","year":"2018","unstructured":"Kotwal A, Clark J, Lyden M, McKenzie T, Thompson G, Stan MN (2018) Thyroidectomy for amiodarone-induced thyrotoxicosis: mayo clinic experience. J Endocr Soc 2(11):1226\u20131235","journal-title":"J Endocr Soc"},{"key":"2168_CR64","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1530\/EJE-19-0515","volume":"181","author":"I Campi","year":"2019","unstructured":"Campi I, Perego GB, Ravogli A, Groppelli A, Parati G, Persani L et al (2019) Pulsed intravenous methylprednisolone combined with oral steroids as a treatment for poorly responsive type 2 amiodarone-induced thyrotoxicosis. Euro J Endocrinol. 181:519","journal-title":"Euro J Endocrinol."},{"issue":"11","key":"2168_CR65","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1007\/s40618-020-01252-2","volume":"43","author":"D Cappellani","year":"2020","unstructured":"Cappellani D, Urbani C, Manetti L, Martino E, Bartalena L, Bogazzi F (2020) Effect of high-dose intravenous glucocorticoid therapy on serum thyroid hormone concentrations in type 2 amiodarone-induced thyrotoxicosis: an exploratory study. J Endocrinol Invest 43(11):1637\u20131643","journal-title":"J Endocrinol Invest"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-023-02168-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-023-02168-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-023-02168-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T21:35:32Z","timestamp":1708032932000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-023-02168-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,20]]},"references-count":65,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["2168"],"URL":"https:\/\/doi.org\/10.1007\/s40618-023-02168-3","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,20]]},"assertion":[{"value":"10 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any study with human participants or animals.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"For this type of study, formal consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}